Drugs / Follitrophin alpha
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT01969201 Comparator | Jan 2014 → Jun 2016 | infertility disorder | IBSA Institut Biochimique SA | Completed | Missed primary |
| Phase 4 | NCT01225835 Comparator | Oct 2010 → Jan 2013 | female infertility | Ferring Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Follitrophin alpha | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01225835 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant Follicle Stimulating (rFSH, Follitrophin Alpha)” NCT01225835 ↗ |
| Route | Subcutaneous | “75 IU/vial powder and solvent for solution for subcutaneous injection” NCT01969201 ↗ |